Related Experiment Video
Updated: May 25, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetics of hypertrophic and dilated cardiomyopathy
Felix W Friedrich1, Lucie Carrier
1Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Insights
Cardiomyopathies are heart muscle diseases. This review focuses on hypertrophic and dilated cardiomyopathies, exploring their genetic causes, molecular mechanisms, and genotype-phenotype relationships in familial cases.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiomyopathies are broadly classified as extrinsic (e.g., hypertension, ischemia) or intrinsic (primary myocardial diseases).
- Primary cardiomyopathies include hypertrophic, dilated, restrictive, and arrhythmogenic right ventricular forms.
- Hypertrophic and dilated cardiomyopathies are the most prevalent primary forms, with significant familial prevalence and genetic heterogeneity.
Purpose of the Study:
- To review current knowledge on causative genes for hypertrophic and dilated cardiomyopathies.
- To elucidate the molecular mechanisms underlying these primary cardiomyopathies.
- To explore the genotype-phenotype correlations in familial cases of hypertrophic and dilated cardiomyopathies.
Main Methods:
- Literature review of causative genes, molecular mechanisms, and genotype-phenotype relations.
- Analysis of diagnostic methods including clinical expression, echocardiography, electrocardiography, non-invasive imaging, and cardiac catheterization.
- Synthesis of current research on familial hypertrophic and dilated cardiomyopathies.
Main Results:
- Identified key causative genes and molecular pathways implicated in hypertrophic and dilated cardiomyopathies.
- Highlighted the genetic and phenotypic diversity within familial forms.
- Established links between specific genotypes and clinical manifestations.
Conclusions:
- Understanding the genetic basis of hypertrophic and dilated cardiomyopathies is crucial for diagnosis and management.
- Further research into molecular mechanisms and genotype-phenotype correlations will advance personalized medicine approaches.
- Familial screening and genetic counseling are important for affected families.
Abstract:
Cardiomyopathies are categorized as extrinsic, being caused by external factors, such as hypertension, ischemia, inflammation, valvular dysfunction, or as intrinsic, which correspond to myocardial diseases without identifiable external causes. These so called primary cardiomyopathies can be categorized in four main forms: hypertrophic, dilated, restrictive, and arrhythmogenic right ventricular cardiomyopathy. Cardiomyopathies are diagnosed by clinical expression, echocardiography, electrocardiography, non-invasive imaging, and sometimes by cardiac catheterization to rule out external causes as ischemia. The two main forms of primary cardiomyopathies are the hypertrophic and dilated cardiomyopathies. Most of hypertrophic cardiomyopathy and 20-50% of dilated cardiomyopathy are familial showing a wide genetic and phenotypic heterogeneity. This review presents the current knowledge on the causative genes, molecular mechanisms and the genotype � phenotype relations of hypertrophic and dilated cardiomyopathies.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure

